BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34962656)

  • 1. COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity.
    Shen Y; Freeman JA; Holland J; Solterbeck A; Naidu K; Soosapilla A; Downe P; Tang C; Kerridge I; Wallman L; Van Bilsen N; Milogiannakis V; Akerman A; Martins Costa Gomes G; Sandgren K; Cunningham AL; Turville S; Mulligan SP
    Br J Haematol; 2022 Apr; 197(1):41-51. PubMed ID: 34962656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.
    Shen Y; Freeman JA; Holland J; Naidu K; Solterbeck A; Van Bilsen N; Downe P; Kerridge I; Wallman L; Akerman A; Aggarwal A; Milogiannakis V; Martins Costa Gomes G; Doyle CM; Sandgren KJ; Turville S; Cunningham AL; Mulligan SP
    Blood; 2022 Dec; 140(25):2709-2721. PubMed ID: 36206503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.
    Shen Y; Freeman JA; Kerridge I; Downe P; Naidu K; Holland J; Mulligan SP
    Br J Haematol; 2024 Feb; 204(2):487-491. PubMed ID: 37669920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
    Muchtar E; Koehler AB; Johnson MJ; Rabe KG; Ding W; Call TG; Leis JF; Kenderian SS; Hayman SR; Wang Y; Hampel PJ; Holets MA; Darby HC; Slager SL; Kay NE; Miao C; Canniff J; Whitaker JA; Levin MJ; Schmid DS; Kennedy RB; Weinberg A; Parikh SA
    Am J Hematol; 2022 Jan; 97(1):90-98. PubMed ID: 34699616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Damery S; Tyson G; Logan N; Davis C; Willett B; Zuo J; Ali M; Kaur M; Stephens C; Brant D; Otter A; McSkeane T; Rolfe H; Faustini S; Richter A; Lee S; Wandroo F; Shafeek S; Pratt G; Paneesha S; Moss P
    J Hematol Oncol; 2022 Jan; 15(1):3. PubMed ID: 35000597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
    Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R
    Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
    Whitaker JA; Parikh SA; Shanafelt TD; Kay NE; Kennedy RB; Grill DE; Goergen KM; Call TG; Kendarian SS; Ding W; Poland GA
    Vaccine; 2021 Feb; 39(7):1122-1130. PubMed ID: 33461835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expansion of CD94/NKG2C
    Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
    Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis.
    Oliva-Ariza G; Fuentes-Herrero B; Lecrevisse Q; Carbonell C; Pérez-Pons A; Torres-Valle A; Pozo J; Martín-Oterino JÁ; González-López Ó; López-Bernús A; Bernal-Ribes M; Belhassen-García M; Pérez-Escurza O; Pérez-Andrés M; Vazquez L; Hernández-Pérez G; García Palomo FJ; Leoz P; Costa-Alba P; Pérez-Losada E; Yeguas A; Santos Sánchez M; García-Blázquez M; Morán-Plata FJ; Damasceno D; Botafogo V; Muñoz-García N; Fluxa R; van Dongen JJM; Marcos M; Almeida J; Orfao A;
    Am J Hematol; 2023 Dec; 98(12):1909-1922. PubMed ID: 37792579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia.
    Whitaker JA; Shanafelt TD; Poland GA; Kay NE
    Clin Adv Hematol Oncol; 2014 Jul; 12(7):440-50. PubMed ID: 25322324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
    Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
    Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal B-cell lymphocytosis; not the same as B-cell chronic lymphocytic leukaemia.
    Svenningsen M; Herborg LL; Hokland P; Ludvigsen M
    Dan Med J; 2017 Dec; 64(12):. PubMed ID: 29206098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
    N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.
    Sorcini D; De Falco F; Gargaro M; Bozza S; Guarente V; Cardinali V; Stella A; Adamo FM; Silva Barcelos EC; Rompietti C; Dorillo E; Geraci C; Esposito A; Arcaleni R; Capoccia S; Mameli MG; Graziani A; Moretti L; Cipiciani A; Riccardi C; Mencacci A; Fallarino F; Rosati E; Sportoletti P
    Br J Haematol; 2023 Apr; 201(1):45-57. PubMed ID: 36484163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.
    Solomon BM; Chaffee KG; Moreira J; Schwager SM; Cerhan JR; Call TG; Kay NE; Slager SL; Shanafelt TD
    Leukemia; 2016 Feb; 30(2):331-6. PubMed ID: 26310541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
    D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G
    Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of transmission of chronic lymphocytic leukemia through blood transfusion.
    Hjalgrim H; Rostgaard K; Vasan SK; Ullum H; Erikstrup C; Pedersen OB; Nielsen KR; Titlestad KE; Melbye M; Nyrén O; Edgren G
    Blood; 2015 Oct; 126(17):2059-61. PubMed ID: 26302757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.
    McCarthy BA; Yancopoulos S; Tipping M; Yan XJ; Wang XP; Bennett F; Li W; Lesser M; Paul S; Boyle E; Moreno C; Catera R; Messmer BT; Cutrona G; Ferrarini M; Kolitz JE; Allen SL; Rai KR; Rawstron AC; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):90-100. PubMed ID: 26318878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal B-cell lymphocytosis: recommendations from the Dutch Working Group on CLL for daily practice.
    te Raa GD; van Oers MH; Kater AP;
    Neth J Med; 2012 Jun; 70(5):236-41. PubMed ID: 22744928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.